Xu, Y.H. and Chen, X.J. (2021) Serum Levels of Apolipoprotein AI (apoAI) in Patients with Endometrial Cancer and Precancerous Lesions and the Inhibitory Effect of apoAI Mimetic Peptide L4F on Endometrial Cancer Cell Proliferation. Fudan Journal (Medical Edition), 1-10.
http://kns.cnki.net/kcms/detail/31.1885.r.20211125.1637.002.html

has been cited by the following article:

• TITLE: Progress in the Study of the Correlation between Apolipoproteins and Endometrial Cancer

  AUTHORS: Luqing Lou, Haibin Zhu

  KEYWORDS: Endometrial Carcinoma, Apolipoprotein, Carcinogenesis

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.10 No.12, December 21, 2022

  ABSTRACT: In recent years, Lipid metabolism disorder has been closely related to malignant tumors. Apolipoprotein (Apo), as an important protein in lipoprotein transport and metabolism, plays an important role in the process of tumor proliferation. Endometrial carcinoma (EC) is a common gynecological malignant tumor, and its incidence is increasing year by year; in which obesity is an independent risk factor for the occurrence and prognosis of EC. This paper discusses the correlation and possible mechanism between different types of Apo and the occurrence, development and prognosis of EC, and briefly reviews the clinical application of some drugs in EC.